Chun‐Lan Chang

529 total citations
27 papers, 400 citations indexed

About

Chun‐Lan Chang is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice and Oncology. According to data from OpenAlex, Chun‐Lan Chang has authored 27 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 6 papers in Family Practice and 5 papers in Oncology. Recurrent topics in Chun‐Lan Chang's work include Heart Failure Treatment and Management (10 papers), Medication Adherence and Compliance (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Chun‐Lan Chang is often cited by papers focused on Heart Failure Treatment and Management (10 papers), Medication Adherence and Compliance (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Chun‐Lan Chang collaborates with scholars based in United States, Australia and Switzerland. Chun‐Lan Chang's co-authors include Daniel H. Solomon, Sebastian Schneeweiß, Seoyoung C. Kim, Gregory W. Daniel, Junjun Liu, Mark J. Cziraky, Debra Wertz, Nancy M. Albert, Jason Swindle and Erin Buysman and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Arthritis Research & Therapy.

In The Last Decade

Chun‐Lan Chang

25 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chun‐Lan Chang United States 11 112 97 70 67 53 27 400
Vasilisa Sazonov United States 13 53 0.5× 28 0.3× 128 1.8× 33 0.5× 315 5.9× 23 526
Shaum Kabadi United States 16 59 0.5× 12 0.1× 29 0.4× 47 0.7× 91 1.7× 36 663
Boglárka Soós Hungary 10 93 0.8× 15 0.2× 24 0.3× 42 0.6× 22 0.4× 30 338
Ralph Quimbo United States 12 55 0.5× 8 0.1× 31 0.4× 48 0.7× 156 2.9× 30 564
Lotfi Chalabi France 11 21 0.2× 52 0.5× 39 0.6× 71 1.1× 137 2.6× 14 472
Aurélien Mary France 12 46 0.4× 6 0.1× 45 0.6× 83 1.2× 57 1.1× 23 517
Aliza Thompson United States 14 38 0.3× 26 0.3× 61 0.9× 80 1.2× 47 0.9× 27 601
Philip A. Kalra United Kingdom 9 63 0.6× 19 0.2× 71 1.0× 33 0.5× 55 1.0× 15 490
Nicholas Sicignano United States 14 12 0.1× 41 0.4× 240 3.4× 124 1.9× 205 3.9× 37 727
Kon‐Siong G. Jie Netherlands 13 41 0.4× 69 0.7× 68 1.0× 44 0.7× 185 3.5× 26 761

Countries citing papers authored by Chun‐Lan Chang

Since Specialization
Citations

This map shows the geographic impact of Chun‐Lan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Lan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Lan Chang more than expected).

Fields of papers citing papers by Chun‐Lan Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Lan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Lan Chang. The network helps show where Chun‐Lan Chang may publish in the future.

Co-authorship network of co-authors of Chun‐Lan Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Lan Chang. A scholar is included among the top collaborators of Chun‐Lan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Lan Chang. Chun‐Lan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lewis, Eldrin F., Theresa Coles, Sandy Lewis, et al.. (2019). Development, psychometric evaluation, and initial feasibility assessment of a symptom tracker for use by patients with heart failure (HFaST). Journal of Patient-Reported Outcomes. 3(1). 26–26. 12 indexed citations
3.
Luo, Nancy, Steven Lippmann, Robert J. Mentz, et al.. (2019). Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure. Journal of the American Heart Association. 8(3). e010484–e010484. 13 indexed citations
4.
Albert, Nancy M., Jason Swindle, Erin Buysman, & Chun‐Lan Chang. (2019). Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure. Journal of the American Heart Association. 8(9). e011089–e011089. 27 indexed citations
5.
Luo, Nancy, Nick Ballew, Emily C. O’Brien, et al.. (2018). EARLY IMPACT OF GUIDELINE PUBLICATION ON ANGIOTENSIN-RECEPTOR NEPRILYSIN INHIBITOR USE AMONG PATIENTS HOSPITALIZED FOR HEART FAILURE. Journal of the American College of Cardiology. 71(11). A791–A791.
6.
Gagne, Joshua J., James R. Rogers, Chun‐Lan Chang, et al.. (2018). Characteristics of early sacubitril/valsartan patients and considerations for studies in electronic health record data. Journal of Comparative Effectiveness Research. 7(11). 1073–1082. 1 indexed citations
7.
Hauber, Brett, et al.. (2017). Quantifying the relative importance to patients of avoiding symptoms and outcomes of heart failure. Current Medical Research and Opinion. 33(11). 2027–2038. 2 indexed citations
8.
Chang, Chun‐Lan, et al.. (2016). Patients' Self-Reported Value of Avoiding Key Heart Failure Outcomes Differs Based on Disease Knowledge. Journal of Cardiac Failure. 22(8). S100–S100. 1 indexed citations
9.
Chang, Chun‐Lan. (2015). Market Orientation, Entrepreneurship, and Product Innovation: Review and Roadmap. SSRN Electronic Journal. 1 indexed citations
10.
Chang, Chun‐Lan, Vernon F. Schabert, Julie Munakata, et al.. (2015). Comparative healthcare costs in patients with metastatic melanoma in the USA. Melanoma Research. 25(4). 312–320. 22 indexed citations
11.
Chang, Chun‐Lan. (2014). Entrepreneurial Orientation, Communication Strategies, and New Product Success: A Theoretic Model. Academy of strategic management journal. 14(1). 1–19. 5 indexed citations
12.
Coritsidis, George, Gregory A. Maglinte, Anjali Acharya, et al.. (2014). Anemia Management Trends in Hospital-Based Dialysis Centers (HBDCs), 2010 to 2013. Clinical Therapeutics. 36(3). 408–418. 5 indexed citations
13.
Pergolizzi, Joseph V., Rami Ben‐Joseph, Chun‐Lan Chang, & Gregory P. Hess. (2014). Predicting Medication Persistence to Buprenorphine Transdermal System. Pain Practice. 15(2). 140–149. 4 indexed citations
14.
Hess, Gregory P., Chun‐Lan Chang, & Karen Chung. (2014). Lipid attainment among patients newly treated with lipid-altering drugs. Current Medical Research and Opinion. 30(9). 1743–1756. 6 indexed citations
15.
Gawęda, Adam E., Premila Bhat, Gregory A. Maglinte, et al.. (2013). TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients. Hemodialysis International. 18(1). 38–46. 14 indexed citations
16.
Kamat, Siddhesh, Michael Bullano, Chun‐Lan Chang, Sanjay Gandhi, & Mark J. Cziraky. (2011). Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population. Current Medical Research and Opinion. 27(5). 961–968. 29 indexed citations
17.
Wertz, Debra, Chun‐Lan Chang, Judith J. Stephenson, Jie Zhang, & Robert J. Kuhn. (2011). Economic impact of tobramycin in patients with cystic fibrosis in a managed care population. Journal of Medical Economics. 14(6). 759–768. 11 indexed citations
18.
Stephenson, Judith J., Chun‐Lan Chang, Gail Wygant, Ole Hauch, & Mark J. Cziraky. (2011). Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US. Current Medical Research and Opinion. 27(6). 1079–1087. 5 indexed citations
19.
Kim, Seoyoung C., Sebastian Schneeweiß, Junjun Liu, et al.. (2010). Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Research & Therapy. 12(4). R154–R154. 170 indexed citations
20.
Chie, Wei‐Chu, et al.. (1996). Geographic variation of breast cancer in Taiwan: international and migrant comparison.. PubMed. 15(6B). 2745–9. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vasilisa Sazonov Breakdown of academic impact, for papers by Shaum Kabadi Breakdown of academic impact, for papers by Boglárka Soós Breakdown of academic impact, for papers by Ralph Quimbo Breakdown of academic impact, for papers by Lotfi Chalabi Breakdown of academic impact, for papers by Aurélien Mary Breakdown of academic impact, for papers by Aliza Thompson Breakdown of academic impact, for papers by Philip A. Kalra Breakdown of academic impact, for papers by Nicholas Sicignano Breakdown of academic impact, for papers by Kon‐Siong G. Jie
Rankless by CCL
2026